Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where SOAR declined for three days, in 200 of 218 cases, the price declined further within the following month. The odds of a continued downward trend are 90%.
The 10-day RSI Indicator for SOAR moved out of overbought territory on September 30, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 31 similar instances where the indicator moved out of overbought territory. In 12 of the 31 cases, the stock moved lower in the following days. This puts the odds of a move lower at 39%.
The Momentum Indicator moved below the 0 level on October 12, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on SOAR as a result. In 46 of 78 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 59%.
The Moving Average Convergence Divergence Histogram (MACD) for SOAR turned negative on October 13, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 50 similar instances when the indicator turned negative. In 26 of the 50 cases the stock turned lower in the days that followed. This puts the odds of success at 52%.
SOAR broke above its upper Bollinger Band on September 28, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 8 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Following a +10.10% 3-day Advance, the price is estimated to grow further. Considering data from situations where SOAR advanced for three days, in 106 of 141 cases, the price rose further within the following month. The odds of a continued upward trend are 75%.
The Aroon Indicator entered an Uptrend today. In 74 of 189 cases where SOAR Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 39%.
The Tickeron Price Growth Rating for this company is 37 (best 1 - 100 worst), indicating steady price growth. SOAR’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 48 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.870) is normal, around the industry mean (2.669). P/E Ratio (-0.309) is within average values for comparable stocks, (16.523). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.284). Dividend Yield (0.000) settles around the average of (0.112) among similar stocks. P/S Ratio (0.106) is also within normal values, averaging (139.965).
The Tickeron PE Growth Rating for this company is 97 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SOAR’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.
The RSI Oscillator for SRTA moved out of oversold territory on October 16, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 33 similar instances when the indicator left oversold territory. In 29 of the 33 cases the stock moved higher. This puts the odds of a move higher at 88%.
The Momentum Indicator moved above the 0 level on October 21, 2026. You may want to consider a long position or call options on SRTA as a result. In 59 of 74 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 80%.
The Moving Average Convergence Divergence (MACD) for SRTA just turned positive on October 20, 2026. Looking at past instances where SRTA's MACD turned positive, the stock continued to rise in 40 of 50 cases over the following month. The odds of a continued upward trend are 80%.
Following a +4.18% 3-day Advance, the price is estimated to grow further. Considering data from situations where SRTA advanced for three days, in 204 of 251 cases, the price rose further within the following month. The odds of a continued upward trend are 81%.
SRTA may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where SRTA declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 85%.
The Aroon Indicator for SRTA entered a downward trend on October 22, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron Seasonality Score of 24 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron PE Growth Rating for this company is 49 (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 54 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of 63 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.492) is normal, around the industry mean (204.132). P/E Ratio (9.612) is within average values for comparable stocks, (18.957). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.498). Dividend Yield (0.000) settles around the average of (0.100) among similar stocks. P/S Ratio (1.730) is also within normal values, averaging (2.688).
The Tickeron Price Growth Rating for this company is 71 (best 1 - 100 worst), indicating slightly worse than average price growth. SRTA’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SRTA’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 85, placing this stock worse than average.
SRTA | ||
|---|---|---|
OUTLOOK RATING 1..100 | 16 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 63 Fair valued | |
PROFIT vs RISK RATING 1..100 | 100 | |
SMR RATING 1..100 | 54 | |
PRICE GROWTH RATING 1..100 | 71 | |
P/E GROWTH RATING 1..100 | 49 | |
SEASONALITY SCORE 1..100 | 24 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
| SOAR | SRTA | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 39% | 1 day ago 88% |
| Stochastic ODDS (%) | 1 day ago 73% | 1 day ago 80% |
| Momentum ODDS (%) | 1 day ago 59% | 1 day ago 80% |
| MACD ODDS (%) | 1 day ago 52% | 1 day ago 80% |
| TrendWeek ODDS (%) | 1 day ago 54% | 1 day ago 84% |
| TrendMonth ODDS (%) | 1 day ago 49% | 1 day ago 81% |
| Advances ODDS (%) | 3 days ago 75% | 2 days ago 81% |
| Declines ODDS (%) | 7 days ago 90% | 9 days ago 85% |
| BollingerBands ODDS (%) | 1 day ago 41% | 1 day ago 80% |
| Aroon ODDS (%) | 1 day ago 39% | 1 day ago 79% |
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
SOAR’s FA Score shows that 1 FA rating(s) are green while SRTA’s FA Score has 0 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
SOAR’s TA Score shows that 3 TA indicator(s) are bullish while SRTA’s TA Score has 5 bullish TA indicator(s).
SOAR (@Information Technology Services) experienced а +4.82% price change this week, while SRTA (@Hospital/Nursing Management) price change was +8.53% for the same time period.
The average weekly price growth across all stocks in the @Information Technology Services industry was -1.75%. For the same industry, the average monthly price growth was -5.55%, and the average quarterly price growth was -7.40%.
The average weekly price growth across all stocks in the @Hospital/Nursing Management industry was +1.24%. For the same industry, the average monthly price growth was -2.96%, and the average quarterly price growth was +22.44%.
SOAR is expected to report earnings on Nov 12, 2026.
SRTA is expected to report earnings on Nov 09, 2026.
The industry, whose total market cap runs into trillions, makes hardware/software that allows data to be stored, retrieved, transmitted, and manipulated on computers. With the ever-increasing relevance of data, the information technology (IT) industry has gained momentous growth over the years, and continues to thrive on innovation. Some of the behemoths in the industry are International Business Machines Corporation, Accenture, and VMware, Inc.
@Hospital/Nursing Management (+1.24% weekly)Hospital/Nursing Management companies own and operate health care facilities. Their operations include nursing homes, acute care facilities, retirement centers and outpatient surgery centers. HCA Healthcare Inc., Alcon Inc. and Universal Health Services, Inc. are some major companies in this industry. Technology has been at the forefront of development of advanced solutions, including quicker diagnoses of complex conditions. Investments in new diagnostics, healthcare IoT, and other healthcare technologies continue to gather momentum in this industry.
A.I.dvisor tells us that SOAR and BBAI have been poorly correlated (+17% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SOAR and BBAI's prices will move in lockstep.
| Ticker / NAME | Correlation To SOAR | 1D Price Change % | ||
|---|---|---|---|---|
| SOAR | 100% | +3.32% | ||
| BBAI - SOAR | 17% Poorly correlated | -2.74% | ||
| SRTA - SOAR | 16% Poorly correlated | -0.42% | ||
| CAAP - SOAR | 13% Poorly correlated | -3.89% | ||
| TDTH - SOAR | 11% Poorly correlated | -9.04% | ||
| UP - SOAR | 11% Poorly correlated | -1.83% | ||
More | ||||
A.I.dvisor indicates that over the last year, SRTA has been loosely correlated with JOBY. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if SRTA jumps, then JOBY could also see price increases.
| Ticker / NAME | Correlation To SRTA | 1D Price Change % | ||
|---|---|---|---|---|
| SRTA | 100% | -0.42% | ||
| JOBY - SRTA | 57% Loosely correlated | +1.29% | ||
| UP - SRTA | 36% Loosely correlated | -1.83% | ||
| AIRS - SRTA | 26% Poorly correlated | -2.34% | ||
| STLN - SRTA | 25% Poorly correlated | +1.17% | ||
| JYNT - SRTA | 24% Poorly correlated | +2.79% | ||
More | ||||